Shares of Pharming Group NV (OTCMKTS:PHGUF – Get Free Report) crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $1.22 and traded as low as $1.1050. Pharming Group shares last traded at $1.1050, with a volume of 1,000 shares.
Pharming Group Price Performance
The stock has a 50 day moving average of $1.21 and a two-hundred day moving average of $1.35. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.31 and a current ratio of 3.01. The firm has a market capitalization of $741.53 million, a P/E ratio of 92.08 and a beta of 0.46.
Pharming Group Company Profile
Pharming Group NV is a Netherlands-based biopharmaceutical company specializing in the development and commercialization of protein replacement therapies for rare diseases. Founded in 1988 and headquartered in Leiden, the company leverages transgenic technology to produce recombinant proteins, with its flagship product RUCONEST (recombinant C1 esterase inhibitor) indicated for the treatment of acute hereditary angioedema (HAE) attacks. RUCONEST is approved and marketed in the United States, Europe and several other territories through partnerships with leading specialty pharmaceutical companies.
Beyond RUCONEST, Pharming maintains a diversified pipeline targeting unmet needs in rare and ultra-rare disorders.
Featured Stories
- Five stocks we like better than Pharming Group
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.
